4//SEC Filing
Tripuraneni Radhika 4
Accession 0000950170-25-038004
CIK 0001590750other
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 4:36 PM ET
Size
5.7 KB
Accession
0000950170-25-038004
Insider Transaction Report
Form 4
Tripuraneni Radhika
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-10+310,700→ 310,700 totalExercise: $15.58Exp: 2035-03-10→ Common Stock (310,700 underlying)
Footnotes (1)
- [F1]The option vests as to 25% on March 10, 2026 and then in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service to Issuer through each vesting date.
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001761114
Filing Metadata
- Form type
- 4
- Filed
- Mar 11, 8:00 PM ET
- Accepted
- Mar 12, 4:36 PM ET
- Size
- 5.7 KB